0001493152-22-005662.txt : 20220228
0001493152-22-005662.hdr.sgml : 20220228
20220228185457
ACCESSION NUMBER: 0001493152-22-005662
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220225
FILED AS OF DATE: 20220228
DATE AS OF CHANGE: 20220228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Huntsman Ronald Kirk
CENTRAL INDEX KEY: 0001835498
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39796
FILM NUMBER: 22692734
MAIL ADDRESS:
STREET 1: 9137 RIDGELINE BOULEVARD, SUITE 135
CITY: HIGHLANDS RANCH
STATE: CO
ZIP: 80129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vivos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001716166
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 813224056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9137 RIDGELINE BOULEVARD
STREET 2: SUITE 135
CITY: HIGHLANDS RANCH
STATE: CO
ZIP: 80129
BUSINESS PHONE: (866)908-4867
MAIL ADDRESS:
STREET 1: 9137 RIDGELINE BOULEVARD
STREET 2: SUITE 135
CITY: HIGHLANDS RANCH
STATE: CO
ZIP: 80129
FORMER COMPANY:
FORMER CONFORMED NAME: Vivos BioTechnologies, Inc.
DATE OF NAME CHANGE: 20170901
4
1
ownership.xml
X0306
4
2022-02-25
0
0001716166
Vivos Therapeutics, Inc.
VVOS
0001835498
Huntsman Ronald Kirk
9137 S. RIDGELINE BLVD, SUITE 135
HIGHLANDS RANCH
CO
80129
1
1
0
0
Chief Executive Officer
Stock Option (Right to Buy)
3.27
2022-02-25
4
A
0
125000
3.27
A
2027-02-25
Common Stock
125000
125000
D
125,000 stock options granted on February 25, 2022. One-fifth vested immediately and one-fifth vests annually on each anniversary date through February 25, 2026.
/s/ Brad Amman as attorney-in-fact for R. Kirk Huntsman
2022-02-28